Lexaria Bioscience Corp. (LEXX): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-08-31, while the company's latest annual report covers the year ended 2025-08-31. Its later filings do not report this line under the concept TickerFacts maps.
$5.81M
As of 2022-08-31
$3.50M
As of 2026-05-31
+65.4%
3-year compound annual growth
+18.1%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2022-08-31 | $5.81M | -46.8% | 2022-11-28, Balance as of period end |
| 2021-08-31 | $10.92M | +743.9% | 2022-11-28, Balance as of period end |
| 2020-08-31 | $1.29M | +0.7% | 2021-11-29, Balance as of period end |
| 2019-08-31 | $1.29M | -25.6% | 2020-10-15, Balance as of period end |
| 2018-08-31 | $1.73M | -31.8% | 2019-11-14, Balance as of period end |
| 2017-08-31 | $2.53M | n/m | 2018-11-14, Balance as of period end |
| 2016-08-31 | $93.4K | -64.1% | 2018-11-14, Balance as of period end |
| 2015-08-31 | $260.1K | -63.0% | 2016-11-29, Balance as of period end |
| 2014-08-31 | $703.0K | n/a | 2015-11-27, Balance as of period end |
| 2013-10-31 | $65.5K | -63.7% | 2014-01-24, Balance as of period end |
| 2012-10-31 | $180.5K | +478.6% | 2014-01-24, Balance as of period end |
| 2011-10-31 | $31.2K | -50.5% | 2013-01-29, Balance as of period end |
| 2010-10-31 | $63.0K | n/a | 2012-01-30, Balance as of period end |